Resmed (ASX:RMD) Chief Executive Michael Farrell sold 8,009 of his shares in the company on the New York Stock Exchange, with an aggregate market value of roughly $1.9 million, according to a Monday filing with the Australian bourse.
Following the transaction, Farrell now owns nearly 146.9 million shares and other units outstanding in the company, the filing said.